Latest Anticonvulsants Stories
WOODCLIFF LAKE, N.J., Oct. 20, 2014 /PRNewswire/ -- Eisai Inc. announced today that the U.S.
RnRMarketResearch.com adds “Partial Seizure – Pipeline Review, H2 2014” to its store.
MarketOptimizer.org adds “PharmaPoint Epilepsy – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store.
NEWARK, Calif., Sept. 5, 2014 /PRNewswire/ -- Depomed, Inc.
- VIMPAT® (lacosamide) C-V approved in the U.S. as monotherapy in the treatment of partial-onset seizures in adults with epilepsy(1) BRUSSELS, Sept.
Eisai Submits Applications for Antiepilepsy Agent Fycompa Simultaneously In Europe and U.S.
Researchers have identified genetic variants that are associated with severe adverse skin reactions to the antiepileptic drug phenytoin.
An Innovative Approach That Puts Clinicians in Charge MAPLE GROVE, Minn., July 28, 2014 /PRNewswire/ -- Upsher-Smith Laboratories,
On July 21, the FDA informed that one lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health Packaging (AHP), are recalled due to mislabeled packaging.
- Brivaracetam is the newest investigational medicine to emerge from UCB's rich late-stage pipeline BRUSSELS, July 23, 2014 /PRNewswire/ -- regulated information -- UCB today announced an important
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.